92 related articles for article (PubMed ID: 29848365)
1. Predicting survival times for neuroblastoma patients using RNA-seq expression profiles.
Grimes T; Walker AR; Datta S; Datta S
Biol Direct; 2018 May; 13(1):11. PubMed ID: 29848365
[TBL] [Abstract][Full Text] [Related]
2. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
3. Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Zhang W; Yu Y; Hertwig F; Thierry-Mieg J; Zhang W; Thierry-Mieg D; Wang J; Furlanello C; Devanarayan V; Cheng J; Deng Y; Hero B; Hong H; Jia M; Li L; Lin SM; Nikolsky Y; Oberthuer A; Qing T; Su Z; Volland R; Wang C; Wang MD; Ai J; Albanese D; Asgharzadeh S; Avigad S; Bao W; Bessarabova M; Brilliant MH; Brors B; Chierici M; Chu TM; Zhang J; Grundy RG; He MM; Hebbring S; Kaufman HL; Lababidi S; Lancashire LJ; Li Y; Lu XX; Luo H; Ma X; Ning B; Noguera R; Peifer M; Phan JH; Roels F; Rosswog C; Shao S; Shen J; Theissen J; Tonini GP; Vandesompele J; Wu PY; Xiao W; Xu J; Xu W; Xuan J; Yang Y; Ye Z; Dong Z; Zhang KK; Yin Y; Zhao C; Zheng Y; Wolfinger RD; Shi T; Malkas LH; Berthold F; Wang J; Tong W; Shi L; Peng Z; Fischer M
Genome Biol; 2015 Jun; 16(1):133. PubMed ID: 26109056
[TBL] [Abstract][Full Text] [Related]
4. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.
Schramm A; Schulte JH; Klein-Hitpass L; Havers W; Sieverts H; Berwanger B; Christiansen H; Warnat P; Brors B; Eils J; Eils R; Eggert A
Oncogene; 2005 Nov; 24(53):7902-12. PubMed ID: 16103881
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients' survival time.
Han Y; Ye X; Cheng J; Zhang S; Feng W; Han Z; Zhang J; Huang K
Biol Direct; 2019 Feb; 14(1):4. PubMed ID: 30760313
[TBL] [Abstract][Full Text] [Related]
6. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
7. An integrated cross-platform prognosis study on neuroblastoma patients.
Chen QR; Song YK; Wei JS; Bilke S; Asgharzadeh S; Seeger RC; Khan J
Genomics; 2008 Oct; 92(4):195-203. PubMed ID: 18598751
[TBL] [Abstract][Full Text] [Related]
8. Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
Schramm A; Vandesompele J; Schulte JH; Dreesmann S; Kaderali L; Brors B; Eils R; Speleman F; Eggert A
Clin Cancer Res; 2007 Mar; 13(5):1459-65. PubMed ID: 17332289
[TBL] [Abstract][Full Text] [Related]
9. CodingQuarry: highly accurate hidden Markov model gene prediction in fungal genomes using RNA-seq transcripts.
Testa AC; Hane JK; Ellwood SR; Oliver RP
BMC Genomics; 2015 Mar; 16(1):170. PubMed ID: 25887563
[TBL] [Abstract][Full Text] [Related]
10. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
[TBL] [Abstract][Full Text] [Related]
11. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
[TBL] [Abstract][Full Text] [Related]
12. Predicting clinical outcomes in neuroblastoma with genomic data integration.
Baali I; Acar DAE; Aderinwale TW; HafezQorani S; Kazan H
Biol Direct; 2018 Sep; 13(1):20. PubMed ID: 30621745
[TBL] [Abstract][Full Text] [Related]
13. RNA-Seq Atlas--a reference database for gene expression profiling in normal tissue by next-generation sequencing.
Krupp M; Marquardt JU; Sahin U; Galle PR; Castle J; Teufel A
Bioinformatics; 2012 Apr; 28(8):1184-5. PubMed ID: 22345621
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
15. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
[TBL] [Abstract][Full Text] [Related]
16. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
[TBL] [Abstract][Full Text] [Related]
18. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics integration for neuroblastoma clinical endpoint prediction.
Francescatto M; Chierici M; Rezvan Dezfooli S; Zandonà A; Jurman G; Furlanello C
Biol Direct; 2018 Apr; 13(1):5. PubMed ID: 29615097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
